Why the study?
What are the long-term clinical outcomes and complication rates associated with the Magovern aortic valve prosthesis in patients with aortic valve disease?
Population
105 patients with aortic valve disease, ages ranging from 21 to 74 years.
Design
Case_series
Follow-up
up to 5 years
Authors
Loading...
High mortality, embolism, and heart block rates caution against Magovern valve use; leaves open durability of contemporary mechanical aortic prostheses.
What are the long-term clinical outcomes and complication rates associated with the Magovern aortic valve prosthesis in patients with aortic valve disease?
The Magovern aortic prosthesis demonstrated acceptable durability if properly sized, but was associated with significant risks of mortality, emboli, and permanent heart block over a 5-year period.
Reed et al. (1971) studied this question.